Percutaneously implanted markers in peripheral lung tumours: Report of complications

Gitte F. PerssonDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkCorrespondence[email protected]

Mirjana JosipovicDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Ditte E. NygaardDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Peter von der ReckeDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Department of Radiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Marianne AznarDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Niels Bohr Institute, Faculty of Science, Copenhagen University, Copenhagen, Denmark

Trine Juhler-NøttrupDepartment of Oncology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmark

Per Munck af RosenschöldDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Niels Bohr Institute, Faculty of Science, Copenhagen University, Copenhagen, Denmark

Stine KorremanDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Niels Bohr Institute, Faculty of Science, Copenhagen University, Copenhagen, Denmark;Department of Science, Systems and Models, Roskilde University, Roskilde, Denmark

Lena SpechtDepartment of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors have received grants from the Danish Council for Independent Research in Medical Sciences, The Arvid Nilssons Foundation, The Astrid Thaysens Foundation and the Lundbeck Foundation Center for Interventional Research in Radiation Oncology (CIRRO). The authors wish to thank Ingemar Näslund for providing the Gold Anchor^TM implantation devices.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Percutaneously implanted markers in peripheral lung tumours: Report of complications

Information for

Open access

Opportunities

Help and information

Percutaneously implanted markers in peripheral lung tumours: Report of complications

Acknowledgements

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature